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a b s t r a c t
Background: The Monetary Incentive Delay task (MID) has been used extensively to probe anticipatory reward processes. However, individual diﬀerences evident
during this task may relate to other constructs such as general arousal or valence processing (i.e., anticipation of negative versus positive outcomes). This investigation
used a latent variable approach to parse activation patterns during the MID within a transdiagnostic clinical sample.
Methods: Participants were drawn from the ﬁrst 500 individuals recruited for the Tulsa-1000 (T1000), a naturalistic longitudinal study of 1000 participants aged 18–
55 (n = 476 with MID data). We employed a multiview latent analysis method, group factor analysis, to characterize factors within and across variable sets consisting
of: (1) region of interest (ROI)-based blood oxygenation level-dependent (BOLD) contrasts during reward and loss anticipation; and (2) self-report measures of positive
and negative valence and related constructs.
Results: Three factors comprised of ROI indicators emerged to accounted for >43% of variance and loaded on variables representing: (1) general arousal or general
activation; (2) valence, with dissociable responses to anticipation of win versus loss; and (3) region-speciﬁc activation, with dissociable activation in salience versus
perceptual brain networks. Two additional factors were comprised of self-report variables, which appeared to represent arousal and valence.
Conclusions: Results indicate that multiview techniques to identify latent variables oﬀer a novel approach for diﬀerentiating brain activation patterns during task
engagement. Such approaches may oﬀer insight into neural processing patterns through dimension reduction, be useful for probing individual diﬀerences, and aid
in the development of optimal explanatory or predictive frameworks.

1. Introduction
Responding to motivationally salient appetitive and aversive stimuli is considered a fundamental process guiding human behavior. As
such, much empirical work has been conducted on measuring reward
and loss processing as well as positive and negative aﬀect in both subjective experience (i.e., self-report) (Salsman et al., 2013; Watson and
Clark, 1999) and in objective metrics (e.g., behavior, neuroimaging)
(Bradley et al., 2001; Knutson et al., 2001a; Knutson and Greer, 2008;
Wilson et al., 2018; Oldham et al., 2018). This ﬁeld of measurement
has been instrumental in informing our understanding of human behavior in normative conditions (Knutson and Greer, 2008) as well as
in the context of cognitive and emotional disorders (Cuthbert and Insel, 2013; Knutson and Heinz, 2015). In particular, the study of reward and loss processing has been widely used in studying addiction
(Balodis and Potenza, 2015), depression (Zhang et al., 2013), and anxiety (Gorka et al., 2018; Maresh et al., 2014; Guyer et al., 2012). Thus,
reﬁning metrics of reward and loss processing has wide ranging applica-
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tions from understanding basic functioning to developing disease models and informing intervention and prevention eﬀorts.
The Monetary Incentive Delay task (MID) (Knutson et al., 2001a)
is among the most common paradigms employed in neuroimaging research to examine reward and loss processing. Research using the task
has had a large impact on our understanding of motivationally salient
stimuli processing, decision making, and goal directed behavior. A key
advantage of this paradigm is the ability to probe both anticipation and
receipt of reward and loss (Knutson and Greer, 2008). The inclusion of
gain and loss conditions enables direct comparison of opposing aﬀective valance or reinforcement processing. Early MID research, in conjunction with functional magnetic resonance imaging (fMRI), focused
particularly on reward anticipation and processing demonstrated that
the nucleus accumbens (NAcc) is recruited during reward anticipation
(even more so than during receipt of reward) (Knutson et al., 2001a) and
is sensitive to degree of reward (Knutson et al., 2001b). Meta-analytic
work indicates that the striatum more broadly (both ventral and dorsal)
is active during anticipation of reward and loss (Oldham et al., 2018)
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and whole-brain analyses have provided a more holistic understanding
of the regions involved in reward and loss anticipation (Wilson et al.,
2018). These ﬁndings suggest that a broader network of regions is involved in reward anticipation (i.e., right NAcc, middle frontal gyrus
[MFG], inferior frontal gyrus [IFG], paracentral lobule, left occipital
gyrus, and left parahippocampal gyrus; superior temporal gyrus [STG]
and left angular gyrus) versus loss anticipation (i.e., parieto-occipital
transition, right supramarginal gyrus, left hippocampus [l-HIPP], right
fusiform gyrus, and left MFG), and some regions are involved in both
(i.e., superior frontal gyrus. [SFG], caudate, putamen) (Wilson et al.,
2018).
The simplicity of the MID makes this task a viable candidate to examine neural anticipatory reward processing impairments as a function of psychopathology as well as a useful tool to determine whether
these diﬀerences can be used to predict clinically meaningful outcomes.
The MID demonstrates promising clinical utility in mental health research and has been especially informative in addiction (Balodis and
Potenza, 2015) and depression (Zhang et al., 2013), and with burgeoning research in anxiety (Gorka et al., 2018; Maresh et al., 2014;
Guyer et al., 2012). Addiction has been associated with modulated (often attenuated) ventral striatum (VS) activation in anticipation of reward; however, the consistency and nature of the VS modulation is
less clear due to variability in examination of state vs. trait drug inﬂuences, task design, and analytic diﬀerences (e.g., gain vs. loss contrast
calculations) (Balodis and Potenza, 2015). Major depressive disorder
has also been associated with attenuated VS activation during reward
anticipation, though this is not consistent across studies (Knutson and
Heinz, 2015). Instead, meta-analytic analyses of monetary gain anticipation in depression suggests attenuated caudal response and heightened
responding of the MFG (Zhang et al., 2013).
Theoretical models of emotional motivation posit that emotion is
characterized by valence and arousal (Bradley et al., 2001) and numerous self-report measures have attempted to account for these factors
(Watson and Clark, 1999; Lang, 1995). It is less known if brain responses
occur in terms of such dimensions or may be represented by diﬀerent
factors. It also is unclear from previous work whether the various regions recruited during MID anticipation reﬂect similar processing distinctions (e.g., arousal or general task activation) or if diﬀerent regions
contribute to distinct cognitive-emotional processing (e.g., valence processing, gain/loss discrimination). Multiview machine learning analytic
frameworks provide an avenue for examining the inﬂuence of diﬀerent
modes of data in concert, so that each compliments the other and improves learning (Nguyen and Wang, 2020). Such exploratory techniques
(e.g., group factor analysis; GFA) may be helpful in delineating these relevant neural dimensions. Identifying such dimensions of neural response
may be important for (1) enhancing our basic understanding of how the
brain processes information; and (2) characterizing when functioning is
awry in the case of neurological or psychiatric conditions. The current
study aims to extend the utility of the MID through (1) identifying latent variables of regional brain activation during anticipation of reward
and loss; and (2) determining whether neural factors relate to self-report
factors of positive and negative valence. This will be accomplished using group factor analytic approaches of the MID and several relevant
self-report measures within the ﬁrst 500 individuals recruited for the
Tulsa-1000 (T1000), a naturalistic longitudinal study of 1000 people,
the majority treatment-seekers for psychiatric disorders (Victor et al.,
2018). Factor analytic techniques oﬀer a novel approach to indexing regional blood oxygenation level-dependent (BOLD) fMRI responses and
disentangling latent variables of neural processing. Speciﬁcally, GFA is
an unsupervised exploratory analysis which extends traditional factor
analytic techniques to reveal latent dependencies in data within and
between groups in the data structure (Klami et al., 2015). The current
study examined activations corresponding to recent meta-analytic ﬁndings of MID anticipation (Wilson et al., 2018) using Brainnetome atlas
regions of interest (ROIs) (Fan et al., 2016). Furthermore, we examined
the potential for latent variables to explain variability across brain de-

rived and self-report variables as well as their relationship to symptoms
and/or diagnosis of substance use, depression, and anxiety disorders.
2. Materials and methods
2.1. Participants
Participants included the ﬁrst 500 participants to complete the baseline assessment in the Tulsa-1000 (T1000) study (Victor et al., 2018),
which recruited treatment seeking individuals with mood, anxiety, substance use and eating disorders, as well as healthy controls, aiming to
identify brain, behavioral, self-report, physiology, and blood-based variables that can be linked to clinically useful treatment predictions. This
parent project included participants 18–55 years screened for inclusion
on the basis of the following scores: (1) Patient Health Questionnaire
(PHQ-9) (Kroenke et al., 2001) ≥10; (2) Overall Anxiety Symptom and
Impairment Scale (OASIS) (Skinner, 1982) ≥8; (3) Drug Abuse Screening Test (DAST-10) (Norman et al., 2006) ≥3 and/or (4) Eating Disorder Screening (SCOFF) ≥2. Additionally, healthy controls with no psychiatric diagnoses or elevation in symptoms were included. Exclusion
criteria were positive urine drug screen; lifetime bipolar, schizophrenia
spectrum, antisocial personality, or obsessive compulsive disorders; active suicidal ideation with intent or plan; moderate to severe traumatic
brain injury; severe and or unstable medical concerns; changes in psychiatric medication dose in the last 6 weeks; and fMRI contraindications
(e.g., metal in body). Full exclusion criteria can be found in the parent
project protocol paper (Victor et al., 2018). The protocol was approved
by the Western Institutional Review Board. All participants provided
written informed consent prior to participation, in accordance with the
Declaration of Helsinki, and were compensated for participation. ClinicalTrials.gov identiﬁer: #NCT02450240.
After exclusion criteria, the current investigation included 476 participants after removing those with unusable fMRI data (e.g., excessive
motion, i.e., participants with average Euclidian norm values across all
repetition time intervals (TRs) >0.3; or no MID data available). All participants were administered the MINI International Neuropsychiatric Interview (6.0 or 7.0) (Sheehan and Lecrubier, 2010; Sheehan et al., 2015)
by study staﬀ to evaluate lifetime mental disorders, deﬁned by the Diagnostic and Statistical Manual of Mental Disorders (4th or 5th Edition)
(American Psychiatric Association 2000; American Psychiatric Association 2013). Sample demographic information, and screening measure
scores are described in Table 1.

2.2. Procedure
General procedures comprised a clinical interview session and a neuroimaging session completed within two weeks on average (Victor et al.,
2018). Although the parent project (i.e., T100018 ) consisted of a broader
range of protocols, only details relevant to the current study are presented here.
2.2.1. Clinical interview and measures
Study staﬀ administered the MINI clinical interview. During this
session, participants also provided self-reported information on demographics (i.e., age, education, income, ethnicity, and race), anxiety, approach and avoidance motivation, depression, emotional processing, impulsivity, pleasure, substance use, and trauma. We identiﬁed the following measures as relevant to positive and negative aﬀect (1) Toronto
Alexithymia Scale (TAS) (Bagby et al., 1994); (2) Temporal Experiences
of Pleasure Scale (TEPS) (Gard et al., 2006); (3) Behavioral Activation
(BAS) Scale (Carver and White, 1994); (4) Positive and Negative Aﬀect
Scales, Expanded Form (PANAS-X) (Watson and Clark, 1999); (5) UPPSP
impulsive behavior scale (Whiteside et al., 2005) (6) Patient Reported
Outcomes Measurement System/Neurology Quality of Life Neuro positive aﬀect and wellbeing (PROMIS/Neuro-QOL-PAW) (Salsman et al.,
2
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Table 1
Descriptive statistics (n = 476) for all demographic and self-report variables.
Mean (SD)

Range

Skew

Kurtosis

Age
34.42(10.57)
18–55
0.58
−1.67
Education
5.94(1.88)
1–11
0.39
−0.96
PHQ-9
9.27(6.57)
0–27
−0.42
−0.17
OASIS
7.50(4.75)
0–20
0.26
−0.80
DAST-10
2.75(3.63)
0–10
−0.07
−0.95
BAS-Drive
10.98(2.71)
4–16
0.90
−0.87
BAS-Fun seeking
11.68(2.54)
5–16
−0.16
−0.41
−0.49
BAS-Reward
17.19(2.16)
9–20
−0.38
PANASX-Negative
20.66(7.90)
10–45
−0.82
0.80
PANASX-Positive
28.64(8.63)
10–50
0.59
−0.28
PROMIS/Neuro-QOL PAW
49.81(7.46)
32–68
0.12
−0.57
TAS- Diﬃculty
16.87(3.55)
7–33
0.36
−0.11
TAS- External Thinking
26.09(10.35)
8–40
0.21
−0.74
TAS- total
57.44(10.35)
20–96
−0.40
1.89
TEPS-Anticipatory
43.17(8.59)
14–60
0.01
0.27
16–48
−0.55
0.06
TEPS-Consummatory
38.47(6.38)
UPPSP-Negative
30.24(7.71)
12–47
−0.78
0.26
UPPSP-Positive
26.70(9.81)
14–56
−0.26
−0.59
Sex: Female (n = 304; 63.9%); Male (n = 172; 36.1%)
Diagnosis: HC (n = 58), ANX(n = 17), MDD (n = 70), MDD+ANX (n = 164), SUD (n = 149), ED (n = 18)

Note: PHQ-9 = Patient Health Questionnaire; DAST-10 =; OASIS =; BAS = Behavioral Activation Scale;
PANAS-X = Positive and Negative Aﬀect Scales, Expanded Form; PROMIS/Neuro-QOL-PAW = Patient Reported Outcomes Measurement System/ Neurology Quality of Life Neuro positive aﬀect and wellbeing;
TAS= Toronto Alexithymia Scale; TEPS = Temporal Experiences of Pleasure Scale; UPPSP = Urgency,
Premeditation, Perseverance, Sensation seeking, and Positive Urgency; HC = Healthy Control, ANX = anxiety only, MDD = depression only, MDD+ANX = comorbid anxiety and depression, SUD = substance use
disorder, ED = eating disorder.

2013). We used the following scales as indices for relevant symptomatology: PHQ-921 ; DAST-1022 ; OASIS (Norman et al., 2006).

quently, data were despiked, corrected for slice timing, co-registered to
anatomical volumes, corrected for motion, smoothed (4 × 4 × 4 mm3 full
width at half maximum), and normalized to Montreal Neurological Institute (MNI) standard space (resampled voxel size 2 × 2 × 2 mm3 ). A general linear model was used to apply boxcar regressors, deﬁned for single
participant data, to the BOLD response during the anticipation phase of
the MID. The boxcar regressors were 4 s duration, made by convolving
AFNI’s BLOCK function of width 4 s with the event times. The ﬁrst 4
polynomial baseline terms were included, along with 6 motion parameters (roll/pitch/yaw/x/y/z translation), and task conditions loss, gain,
no loss, no gain. Model ﬁts resulting from single subject general linear
models (i.e., beta coeﬃcients for condition contrasts gain minus no gain
and loss minus no loss) were extracted for the GFA analyses (Figure S2).
Data were then extracted for ROIs corresponding to recent meta analytic
work on the anticipation phase of the MID (basal ganglia[BG], cingulate gyrus[CG], fusiform gyrus[FuG], hippocampus[Hipp],insula[INS],
inferior parietal lobule[IPL], inferior temporal gyrus[ITG], lateral occipital cortex[LOcC], middle frontal gyrus[MFG], paracentral lobule[PCL],
parahippocampal gyrus[PhG], superior frontal gyrus [SFG], and superior temporal gyrus [STG]) (Wilson et al., 2018) using the Brainnetome
Atlas (Fan et al., 2016; speciﬁc Brainnetome labels ROIs are reported in
supplemental materials; Table S1) all regions were examined bilaterally
for use in GFA. When extracting contrast for an ROI, only voxels with a
temporal signal to noise ratio of greater than 50 were included.

2.2.2. Neuroimaging session
Participants engaged in 90 trials of the MID (Knutson et al., 2001a)
for approximately 19 min (i.e., two runs: 45 trials/run, 568 s/run). Trials
consisted of three visual stimuli: cue stimulus (2 s) indicating potential
gain (circle), loss (square), or neither (circle or square); a 2.25–3 s delay; target (approximately 250 ms, white triangle) requiring a button
press; a response window (approximately 1.25 s); and feedback (2 s)
indicating the outcome (i.e., gain, loss, or no change). Magnitude of
potential gains and losses was indicated using the placement of a line
presented in the cue: a line toward the bottom of the cue = no win or
loss; a line in the middle of the cue = low win or loss (+/- $1); a line
at the top of the cue = high win or loss (+/- $5). Text below the cue
also indicated potential gains/losses (−5/−1/−0/+0/+1/+5). In order
to obtain a gain or avoid a loss, participants were required to press a button as fast as possible following the target stimulus (Figure S1). Time
range of responses needed for success were individually calibrated to
each participant’s reaction time (RT) during a pre-scan practice session
to a hit rate of 66%. On average participants earned $30 during the
task, paid as a bonus in addition to their standard compensation. fMRI
images during the MID were acquired with two identical GE MR750
3T scanners consisting of contiguous echo-planar imaging (EPI) volumes (39 axial slices, TR/TE = 2000/27 ms, FOV/slice = 240/2.9 mm,
128 × 128 matrix). Additionally, high-resolution structural images
were obtained through a 3D axial T1-weighted magnetization-prepared
rapid acquisition with gradient echo sequence (TR/TE = 5/2.0 12 ms,
FOV/slice = 240 × 192/0.9 mm, 186 axial slices).

2.4. Analytic strategy
Analyses were conducted in R 3.6.1 (R Core Team 2019) using
RStudio 1.1463 (RStudioTeam 2016) and RMarkdown (Allaire et al.,
2020; Xie et al., 2018), employing the following packages: chemometrics (Filzmoser and Varmuza, 2017), DMwR (Torgo, 2010), GFA
(Virtanen et al., 2012), ggplot2 (Wickham, 2016), psych (Revelle, 2018),
and stats (R Core Team 2019). Missing questionnaire data were imputed
using K nearest neighbor imputation for GFA. All R and R Markdown
scripts are available as html documents in the supplemental materials
and can be found on Open Science Framework (https://osf.io/32kpn/).

2.3. Neuroimaging data processing
Processing and analyses of neuroimaging data were conducted using
Analysis of Functional Neuroimaging (AFNI, http://anﬁ.nimh.nih.gov)
software (Cox, 2012). The ﬁrst three EPI volumes for each run were discarded to account for signal stabilization and noise adaptation. Subse3
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2.5. Group factor analysis

2.7. Behavioral and demographic analyses

GFA (Klami et al., 2015) was used as a multiview method to identify
patterns of activation across diﬀerent groups (i.e., views) of measures.
Two groups were deﬁned: 1) BOLD ROI contrasts (i.e., gain/loss anticipation); and 2)self-report measures. GFA employs Bayesian inference to
assign automatic relevance determination priors on the factor solution,
assuming low-rank representation of factor loadings (Tipping, 2001).
Estimation in the current analysis employed a full rank approach
(Klami et al., 2015; Virtanen et al., 2012). The model included 248 ROI
and 13 self-report predictors (subject to predictor ratio of 1.82). Previous simulation research utilizing Bayesian inference to prevent overﬁtting has demonstrated the adequate performance of GFA in subject to
predictor ratios from 30:28 (1.07) up to 30:700 (0.04); thus the current
ratio of 1.8 (476:261) is appropriate (Klami et al., 2015). Furthermore,
GFA results could depend on initial values of parameters so we replicated estimation 10 times and extracted robust factors that cohere across
10 replicates of the factor analysis. The speciﬁc matching procedure (the
robustComponents function in the GFA package) was described as follows: (1) factor loadings of a factor from a replicate were correlated to
loadings of all factors in another replicate, (2) the factor showing the
strongest correlation across replicates, and for which the correlation exceeded a threshold (corThr) was considered “matched”; (3) repeat Steps
(1) and (2) for all replicates and claim a factor “robust” if the proportion of “matched” across replicates exceeded a threshold (matchThr).
With this matching procedure, we obtained a number of robust factors
for a given pair of threshold parameters. However, diﬀerent threshold
parameters might lead to diﬀerent numbers of robust factors. We thus
conducted a 7 × 7 grid search on values of 0.1, 0.3, 0.5, 0.6, 0.7, 0.8, and
0.9 for the (corTh, matchThr) pairs. For each parameter pair, we reconstructed the data by multiplying the robust factor loadings and scores,
which were compared to the observed data by mean-square-error (MSE).
The optimal threshold parameter pair was then chosen by the one that
gave the fewest robust factors with MSE within 1 standard error of the
minimal MSE across all pairs. GFA enables the examination of variance
within a group of variables, but also covariance between the sets. Thus,
the advantages for this particular study are two-fold: (1) characterizing
factors related to both BOLD signal contrasts and self-report measures of
interest; and (2) determining if factors have relationships to both neural
activation and self-report measures. Factors presented here were chosen based on either accounting for at least 3% percent of overall model
variance or 10% of variance within a set of variables (i.e., BOLD ROIs,
self-report).

We also examined Spearman’s correlations between factor scores and
MID RT by conditions (high magnitude gains/losses, neutral outcome).
Furthermore, we examined the relationship of the factor scores with sex,
age, and education level using Welch’s independent sample t-test, linear
regression, and one-way ANOVA respectively.
3. Results
GFA output from R along with full resolution images of the factor
loading plots for latent variables of interest can be found on Open Science Framework https://osf.io/32kpn/.
3.1. Demographics and sample characteristics
Table 1 presents the demographic information of the current sample
as well as descriptive statistics regarding self-report measures of symptoms and positive and negative valence.
3.2. GFA examining bold signal response and self-reported
positive/negative valence
Distribution and correlations of factor scores can be found in the
supplement demonstrating the assumption of orthogonality was met
(Figures S3 and S4). Twenty-nine factors were extracted, together accounting for 63.6% of the total variance. This included three factors
accounting for >3% of the total variance across both the brain imaging
and self-report variable sets; and two additional factors that explained
>10% variance within the self-report variable set (no additional factors
were identiﬁed that accounted for >10% in the brain imaging variable
set). These ﬁve factors accounted for 49.42% of the overall variance.
Notably the two factors speciﬁc to the self-report variables accounted
for only 2.37% of the variance in the total model due to there being a
much larger number of ROI contrast variables (n = 248) in the model
relative to self-report variables (n = 13). Combined the two self-report
factors extracted accounted for 42.65% of variance within the self-report
variables. Thus, these ﬁve factors were interpreted and used for further
analysis. Median strongest correlation values of the robust factors across
the 10 replicates conducted in the GFA indicated that the robust factors
were reliable (all r’s > 0.8; Fig. 1). The ﬁrst three factors identiﬁed only
included ROI contrast variables, with no signiﬁcant loadings observed
for self-report variables. The ﬁrst factor (F1; arousal/general task activation factor) accounted for 24.61% of the overall variance in the model.
All loadings were positive across conditions (i.e., gain, loss), indicating that F1 represented an overall activation, or valence-independent
general activation (Fig. 2). The second (F2; valence/condition discrimination factor) accounted for 19.24% of the overall variance. Indicators
from the gain anticipation condition loaded positively and the loss anticipation condition negatively, indicating that F2 may represent diﬀerentiation of activation according to valence (Fig. 3). The third factor
(F3; region speciﬁc factor) accounted for 3.2% of the overall variance.
The loadings on this factor seemed to diﬀerentiate according to brain
region, with higher loadings for gain conditions. Strong positive loadings were observed for subcortical (i.e., striatum, insula, hippocampus,
basal ganglia), cingulate, and superior temporal regions, whereas strong
negative loadings were observed for inferior parietal, inferior temporal,
middle frontal, and occipital cortical regions (Fig. 4).
Factor 22 (F22) and factor 26 (F26) are interpreted here given that
they accounted for a signiﬁcant amount of variance in the self-report
variable block. F22 (self-report valence factor) accounted for 29.4% of
the variance among self-report variables (1.47% overall). Importantly
the amount of variance accounted for among all predictors was low
likely due to the large number of ROI predictors in the model resulting
in high factor numbers (22 and 26). However, they do predict a large
amount of variance within their particular group (view; i.e. self-report)

2.6. General linear models (GLM)
We conducted follow-up GLM analyses to explore the potential clinical signiﬁcance of identiﬁed factors. Participants were grouped by
diagnosis as determined by the MINI (Sheehan and Lecrubier, 2010;
Sheehan et al., 2015), including major depressive disorder only (‘MDD’),
anxiety disorders only (‘ANX’; social anxiety, generalized anxiety, panic,
or posttraumatic stress disorder), comorbid MDD and anxiety disorders
(‘MDD+ANX’), substance use disorders (‘SUD’; recreational drugs, excluding alcohol or nicotine; with or without comorbid ANX/MDD), eating disorders (‘ED’; with or without comorbid MDD, ANX, or SUDs),
and healthy comparisons with no psychiatric diagnoses (‘HC’) as in
(Aupperle et al., 2020). We conducted separate one-way ANOVAs to
examine mean diﬀerences on each of the ﬁve factor scores extracted
(criteria detailed above) according to diagnosis (6 levels; HC, ANX,
MDD, MDD+ANX, SUD, ED). Bonferroni correction performed for multiple comparison in post-hoc analyses when relevant. Similarly, regression
models were employed to examine relationships between symptoms of
depression (PHQ-9), anxiety (OASIS), and substance use (DAST-10) and
each of the factor scores.
4
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Fig. 1. Median correlation values of the robust
factors across all 10 replicates of the GFA. Values indicate good to excellent reliability.

and demonstrated high coherence across replicates (see: Fig. 1). The
pattern of loadings indicated that positive aﬀect, pleasure, and approach
motivation variables loaded positively, and negative aﬀect, alexithymia,
and impulsivity loaded negatively, (Fig. 5). F26 (arousal/response intensity factor) accounted for 13.25% of the variance in the self-report variables (0.9% overall) and all self-report indicators loaded signiﬁcantly in
the same direction, with the exception of PANAS-X positive aﬀect and
PROMIS wellbeing, which did not load signiﬁcantly (Fig. 6). In addition
to self-report loadings, some ROI indicators loaded onto F26; however,
these loadings were not interpreted, as the general pattern of standard
errors included zero with the exception of the parahippocampal gyrus
in the gain condition. Notably, F26 accounted for only 0.23% of variance among the ROI contrast variable set. Notably, no identiﬁed factor
is related to dependencies between ROI and self-report variable groups.

3.4. Demographic and behavioral data results
Independent samples t-tests indicated that no factor scores diﬀered
by sex (p’s = 0.13–0.71) with the exception of the valence/condition
discrimination factor, t(375.98) = −1.99, p = 0.046, d = 0.21, such that
males (M = 0.12) had higher scores than females (M = −0.06), indicative of greater diﬀerential activation during gain anticipation as compared to loss anticipation. Regression models indicated that age did not
predict any factor scores (p’s = 0.06–0.94) with the exception of the region speciﬁc factor (𝛽 =0.11, p = 0.015, R2 adj = 0.01) indicating that
older participants demonstrated larger diﬀerentiation between subcortical, superior temporal, and cingulate regions as compared to inferior
parietal, inferior temporal, middle frontal, and occipital cortical regions.
Though signiﬁcant, eﬀect sizes of these ﬁndings were small, accounting
for approximately 1% of the variance. ANOVA also revealed that education did not predict any of the factor scores (p’s = 0.38–0.97). Correlations indicated that there were no signiﬁcant associations between RT
in any MID condition and factor scores (Figure S3).

3.3. GLMs
ANOVA models indicated that no factor score means diﬀered across
diagnostic groups (p’s = 0.16–0.67), with the exception of the self-report
valence factor (F(5,460) = 2.35, p = 0.0402) . Pairwise comparisons indicated that HC had a higher mean score (M = 0.24) relative to individuals
with MDD only (M = −0.23; d = 0.53, CI95 [0.18–0.89]), indicative of
higher positive and lower negative aﬀect. It is important to note that
the omnibus eﬀect would not survive correction for multiple comparisons. Regression analyses were also non-signiﬁcant for all factors and
symptom measure scales (p-values = 0.06–0.95) with the exception of
the OASIS score relating negatively to the self-report valence factor (𝛽
=−0.09, p = 0.039, R2 adj = 0.007).

4. Discussion
The current study applied a multi-view method, group factor analysis (GFA), to fMRI BOLD signal contrasts elicited by anticipation of high
magnitude gain and loss outcomes relative to neutral outcomes during
the MID task and relevant self-report indicators of positive and negative
aﬀect. Factors of interest were examined for their relationship with psychopathology diagnoses and symptoms. Results indicate that GFA identiﬁed factors corresponding to BOLD signal activity indexing: general task
activation, discrimination of gain/loss anticipation, and region-speciﬁc
5
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Fig. 2. Factor loadings for the F1 (i.e., arousal/general task activation) resulting from GFA. Median factor loadings and 95% conﬁdence interval are presented for
each Brainnetome ROI and were drawn from the GFA W matrix. ROIs are grouped into anatomical regions by condition using brackets and color coding. Labels for
ROI variables include Brainnetome id and anatomical descriptor (r=right; l=left). Individual ROI predictors are grouped into broader regional descriptors: BG=basal
ganglia, CG=cingulate gyrus, FuG=fusiform gyrus, Hip=hippocampus, INS=insula, IPL=inferior parietal lobule, ITG=inferior temporal gyrus, LOcC=lateral occipital
cortex, MFG=middle frontal gyrus, PCL=paracentral lobule, PhG=Parahippocampal gyrus, SFG=superior frontal gyrus, STG= superior temporal gyrus. SR = selfreport variables. MID conditions are organized such that gain (+) is on the left half of the plot and loss (-) is on the right with corresponding anatomical regions
directly across the circle.

activity. Separate factors distinguished patterns of self-report responses
associated with arousal and valence. No factor signiﬁcantly predicted
variance across brain-derived and self-report indicators.

arousal/general task activation factor had loadings with consistent directionality across regions and conditions, suggesting that this factor
may represent overall arousal or attentional processes. Alternatively,
this factor may reﬂect a global BOLD signal inﬂuenced by physiological diﬀerences impacting the BOLD signal. However, if primarily due to
physiological diﬀerences (i.e., in cerebral vasculature), one might expect
the factor to signiﬁcantly correlate with age – which it did not. It will be
useful for future work to identify whether similar factors can be identiﬁed across a variety of tasks and whether the factor is modulated by
experimental manipulation of blood ﬂow or arousal. For example, many

4.1. fMRI bold signal activation contrasts
The factors accounting for the greatest amount of variance in the
overall model (i.e., arousal/general task activation, valence/condition
discrimination, region speciﬁc factors) had signiﬁcant loadings from
the ROI indicators and no loadings from self-report data. The
6
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Fig. 3. Factor loadings for the second factor (i.e., valence/condition discrimination) resulting from group factor analysis. Factor loadings presentation and labels are
consistent with Fig. 2.

factors inﬂuence the BOLD response in addition in neural metabolic
processes, including a wide range of autoregulatory processes, making
cautious interpretation of BOLD signal responding critical (Nair, 2005).
Regardless, a factor analytic approach like used here could be useful for controlling variance associated with arousal or global signal to
allow for more speciﬁc focus on activation relevant to conditions of
interest.
Results suggest that the valence/condition discrimination factor
demonstrate patters of loadings representing distinctions between positive and negative valence or between positive and negative reinforcement (i.e., avoiding loss vs. obtaining gain). The identiﬁcation of such
a factor provides further evidence that such distinction in neural processing exists across a range of brain regions that have been previously
identiﬁed as activated during the MID task. Future research could be

useful to determine whether additional regions other than those focused
on here would also load on a valence-speciﬁc factor, and whether similar valence-speciﬁc factors could be identiﬁed for tasks other than the
MID.
The region-speciﬁc factor may characterize relative activation in circuits associated with salience processing (e.g., striatum, insula) as compared to executive processing (occipital cortex, inferior parietal lobule,
inferior temporal gyrus). The pattern of relative inverse factor loadings
of activation in these regions (i.e., salience vs. executive) may indicate
that individuals down regulate basic attentional processing regions in favor of increasing activation of salience processing during MID anticipation. Importantly, the direction of factor loading (i.e., positive/negative)
is not indicative of brain activation or deactivation; thus, inverse loadings do not imply a particular directionality of brain activity and the
7
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Fig. 4. Factor loadings for the third factor (i.e., region speciﬁc) resulting from group factor analysis. Factor loadings presentation and labels are consistent with
Fig. 2.

alternative hypothesis that these factor loadings represents down regulation in salience processing in favor of executive function regions cannot be ruled out.
Overall these ﬁndings are consistent with theoretical assertions that
anticipatory aﬀect comprises both arousal and valence (Knutson and
Greer, 2008). Importantly, the current results suggest that brain regions active during reward and loss anticipation are involved in both
general salience processing and in discerning potential gain versus
loss. However, these data do not preclude the interpretation that the
arousal/general task activation represent a global signal that may not
be speciﬁc to the MID. As such future GFA work is needed within
other fMRI tasks to determine if region speciﬁc factors in other tasks
relate to previously reports speciﬁc eﬀects. Results also extend recent
research suggesting that particular brain regions are sensitive to an-

ticipated outcomes in the MID (i.e., gain/loss) (Wilson et al., 2018;
Knutson et al., 2001b; Diekhof et al., 2012).Importantly, this previous
empirical work has often been relegated to circumscribed regions such
as Nacc (Knutson et al., 2001b) and VS (Diekhof et al., 2012), which
has been noted as a limitation of this body of literature (Oldham et al.,
2018). Current results support the idea that numerous brain regions
likely respond as part of a broader network during MID anticipation,
consistent with recent meta-analytic data, (Wilson et al., 2018) and extend this literature demonstrating that factors discern arousal and valence in gain and loss anticipation across brain regions. Moreover, ROIs
in the current study loaded on both the arousal factor and valence factor; whereas traditional fMRI analytic approaches may have diﬃculty
discerning these responses, the GFA approach provides an avenue for
distinguishing the two.
8
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Fig. 5. Factor loadings for the fourth factor (i.e., self-report valence) resulting from group factor analysis. Factor loadings presentation and labels are consistent with
Fig. 2.

4.2. Self-report indicators

(i.e., arousal). The pattern of the self-report factors ﬁndings is analogous to the valence and arousal ﬁndings in the ROI valence/condition
discrimination and arousal/general task activation factors. Furthermore,
the distinction between valence and arousal in the self-report factors is
consistent with previous self-report literature (Watson and Clark, 1999;
Lang, 1995). However, PANAS-X positive aﬀect did not load signiﬁcantly and PROMIS/Neuro-QOL-PAW loaded slightly opposite of the
rest of the signiﬁcant loadings on the self-report arousal/response intensity factor. This may indicate that constructs captured on the PANAS-X
(Watson and Clark, 1999) and PROMIS/Neuro-QOL-PAW (items such
as: “proud”, “interested, “inspired”; and feeling “at ease”, “relaxed”,
“peaceful” respectively), while positive, may not be as intense or arousing as what is measured by other scales.

Two factors examined from the GFA represented a signiﬁcant
amount of variance within self-report indicators (i.e., self-report valence factor, self-report arousal/response intensity; Figs. 5and 6). Notably, these factors did not account for much variance in the overall
model due to the relatively fewer predictors as compared to ROI variables. The self-report valence factor displayed pattern of loadings suggesting that it represents discernment of valence across questionnaire
indicators. Positive aﬀect variables, pleasure, approach motivation, and
well-being loaded positively, whereas impulsivity, alexithymia, and negative aﬀect loaded negatively. The self-report arousal/response intensity factor comprised loadings from self-report variables all in a consistent direction, indicating this factor may represent response intensity
9
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Fig. 6. Factor loadings for the ﬁfth factor (i.e., self-report arousal/response intensity) resulting from group factor analysis. Factor loadings presentation and labels
are consistent with Fig. 2.

4.3. Clinical relevance

tion discernment (e.g., valence). Based on these ﬁndings, some readers
may be tempted to call into question the legitimacy of either the MID
or self-report measures as legitimate probes of arousal or valence discernment. However, we would argue that both likely measure legitimate
aspects of these constructs but tap into very diﬀerent features of underlying processes. Given the lack of relationships to self-reported aﬀect,
we hypothesize that the brain derived factors may represent general
neural response functioning which may not involve conscious awareness, whereas self-report derived factors are representative of an individual’s conscious experience of emotions. In other words, if the identiﬁed factors are robust ways in which the human brain responds to
salient stimuli, they may not be as dynamic as one’s state level of arousal
or valence and represent more trait-like measures. Thus, perhaps intermediate or more subtle, region-speciﬁc neural responses (not detected

With respect to psychiatric diagnoses and symptoms, there were no
mean diﬀerences between diagnostic groups on the arousal/general task
activation or valence/condition discrimination factor scores. These factors also did not relate to dimensional psychopathology symptoms. This
is inconsistent with research reporting modulated VS activation in addiction (Balodis and Potenza, 2015), as well as attenuated VS (Knutson and
Heinz, 2015), reduced dorsal striatum, and increased MFG activation
in depression (Zhang et al., 2013). However, these studies focused on
speciﬁc regional activations, not latent variables of neural activation.
The current results indicate that both neural activation during MID and
self-report variables were associated with analogous but distinct pairs
of factors characterizing general activation (e.g., arousal) and condi10
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via GFA) may drive the aﬀect actually experienced by individuals from
one state to another. One possibility to be tested in future work would
be that the brain-derived factors identiﬁed here may be more likely to
relate to more trait-like or “hard-wired” levels of measurement (e.g.,
genetics) whereas the self-report derived factors may be more likely to
relate to functional levels of analyses (i.e., psychiatric symptoms, diagnoses). Accordingly, the only factor which showed any relationship
to our psychiatric measures was the self-report derived valence factor.
Results indicate that healthy individuals endorsed signiﬁcantly higher
self-report valence discernment scores than individuals with depression.
Examination of dimensional symptom measures indicate self-report valence discrimination was only associated with anxiety symptoms, such
that higher anxiety related to lower valence discernment. These results
are consistent with prior work demonstrating blunted emotional valence responding in depression and anxiety (Taylor-Clift et al., 2011;
Sandre et al., 2019; Grant et al., 2015; Dillon et al., 2014)
Results also indicated that men had higher levels of diﬀerential brain
activation between anticipation of gains as compared to losses. These
ﬁndings extend literature indicating diﬀerential reward processing between males and females (Fattore, 2015), in which animal models indicate that females exhibit stimulus directed, as opposed to goal-directed
reward behavior (Hammerslag and Gulley, 2014). Event-related potential analysis indicated that adolescent males had increased responding
to rewards and punishment than adolescent females (Greimel et al.,
2018). Furthermore, results indicated that there was a signiﬁcant association of age and F3, which may reﬂect diﬀerential impacts of age
on regional brain volume across the ROIs or distinct patterns of networkbased activation during gain and loss anticipation. Although the size of
these eﬀects were small, this is consistent with recent work eﬀect sizes
from more traditional ROI based analyses conducted in large samples
designed to reduce false-positive results (Paulus and Thompson, 2019).

Finally, dimensional indicators of psychopathology symptoms employed
in the current study were self-reported, not clinician rated. However,
self-report measures have been reported to converge with clinicianadministered scales (Rush et al., 2006; Löwe et al., 2004). Moreover,
results were consistently null regarding clinician administered interview
(MIN) and self-reported symptom variables.

4.3. Limitations
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4.4. Conclusions
The current analyses provide novel evidence that neural activity during gain and loss anticipation is associated with factors which diﬀerentiate general task activation and condition speciﬁcity. An important next
step in this line of work is to determine if these factors are reproducible
and reliable over time (Bennett and Miller, 2010; Poldrack et al., 2017).
The current study did not demonstrate strong evidence for the relationship between factors and clinically relevant variables but did demonstrate greater diﬀerentiation between gain and loss anticipation among
males compared to females. Also, age was associated with greater distinction between salience and executive function regions. Thus, aforementioned reliability work may support the hypothesis that functional
circuitry indexed during the MID demonstrates integrity in the context
of psychopathology under experimental conditions and clinical disruption may be more nuanced. It would be beneﬁcial for future studies to:
1) examine factors related to various magnitudes of outcomes: and 2) to
manipulate the experimental context during MID (e.g., cognitive load,
level of arousal, modulation of blood ﬂow). Overall, current results indicate that a factor analytic approach may be informative alongside more
traditional fMRI analyses to serve as a general assessment of arousal and
valence processing.
Financial disclosures

A key limitation to the current study is the cross-sectional nature of
the design, precluding interpretation of causal inﬂuences and directionality in identiﬁed relationships. The current analysis only considered
anticipation during high magnitude trials from the MID. Although this
enabled inclusion of a broad range of brain regions implicated in MID
anticipation in previous meta analytic work (Wilson et al., 2018), it is
possible that inclusion of diﬀerent magnitudes could alter the underlying factor structure. We chose to focus on the set of brain regions
and contrasts that we did in order to minimize the number of variables
included in the GFA, in a way that was optimally informed by previous work with the MID. We also chose to focus on mean percent signal
change across the anticipation phase of the task, within predeﬁned regions of interest, as one way of using factor analytic approaches to identify more parsimonious dimensions of interest. We recognize that there
are numerous approaches that can be used to reduce dimensionality of
fMRI data, such as using latent class analysis to identify diﬀerent temporal trajectories of activation throughout the task or the use of voxelbased pattern analysis. The approach taken here provides one strategy
that maintains similarity to more traditional, ROI-based approaches to
analysis, which thus supports interpretation of ﬁndings in relation to
that previous literature.
Additionally, the goal of the T1000 study was longitudinal investigation of dimensional characteristics of a transdiagnostic clinical sample consistent with RDoC recommendations (Victor et al., 2018); thus,
the clinical categories examined in the current study did not account
for comorbidity in the sample or heterogeneity within the SUD group
(e.g., alcohol use disorder). Notably, the sample consisted primarily
of individuals with mood, anxiety, and substance disorders. This may
impact the generalizability of the current ﬁndings. Future work clarifying the relationship between the identiﬁed factor scores and psychopathology would beneﬁt from nuanced consideration of comorbidity
and or explorations of factor structures within various clinical groups.
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